A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction.

Details

Language :

English

ISSN :

01676997

Volume :

29

Issue :

5

Database :

Complementary Index

Journal :

Investigational New Drugs

Publication Type :

Academic Journal

Accession number :

64594702

Full Text :

https://doi.org/10.1007/s10637-010-9399-1